Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells
Liyan Zhang, Nan Li, Ricardo Caicedo, Josef Neu, Liyan Zhang, Nan Li, Ricardo Caicedo, Josef Neu
Abstract
Certain probiotic bacteria show anti-inflammatory activity after being heat killed, whereas others do not, suggesting that the gastrointestinal environment may alter the activity of probiotic bacteria. Occasionally, probiotics are provided when a patient is also being treated with oral antibiotics; this may have an effect on the probiotic activity. We hypothesized that Lactobacillus rhamnosus GG (LGG) are capable of downregulating tumor necrosis factor-alpha (TNFalpha)-induced interleukin (IL)-8 production under all 3 of these conditions, and that LGG act through the nuclear factor kappaB (NFkappaB)/inhibitor of kappaB (IkappaB) pathway. Caco-2 cells were treated with live or heat-killed LGG in doses ranging from 10(4) to 10(10) cfu/L, in the presence or absence of antibiotics and TNFalpha in the media. TNFalpha-induced production of IL-8 by Caco-2 cells was modulated by LGG under all 3 conditions. However, higher doses of live LGG without TNFalpha in the presence or absence of antibiotics in vitro induced the production of IL-8 (P = 0.001). Heat-killed LGG also blunted the TNFalpha-induced IL-8 production (P < 0.01), but by itself did not increase IL-8 production at higher doses as markedly as live LGG (P < 0.05). LGG reduced the TNFalpha-induced NFkappaB translocation to the nucleus and lessened the decrease in IkappaB in the cytoplasm (P < 0.05). LGG reduced TNFalpha-induced IL-8 production by affecting the NFkappaB/IkappaB pathway in Caco-2 cells. High doses of live LGG markedly increased IL-8 production, but heat-killed LGG caused only a slight increase in IL-8. Thus, heat-killed LGG may effectively ameliorate inflammation with a lower potential than live LGG at high doses to cause inflammation.
Source: PubMed
Upcoming Clinical Trials
-
Seoul National University HospitalSamil Pharmaceutical Co., Ltd.RecruitingSarcopenia | Total Knee ArthroplastySouth Korea
-
Stanford UniversityNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative NeoplasmUnited States
-
Cheng QiRecruitingPost-hepatectomy HypoalbuminemiaChina
-
Stanford UniversityNot yet recruitingLiver FailureUnited States
-
Istanbul Aydın UniversityNot yet recruitingNeck Pain | Myofascial Pain Syndrome | Work-Related Musculoskeletal DisordersTurkey (Türkiye)
-
Jonsson Comprehensive Cancer CenterStemline Therapeutics, Inc.Not yet recruitingRecurrent Endometrial Carcinoma | Advanced Endometrial Carcinoma | Metastatic Endometrial Carcinoma | Stage III Endometrial Cancer | Stage IV Endometrial CancerUnited States
-
University of Colorado, DenverRecruitingAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular ScoliosisUnited States
-
University of FloridaAmerican Heart AssociationRecruitingHeart Failure With Preserved Ejection Fraction (HFPEF)United States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingLeukemia | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Acute Leukemia | Acute Lymphoid LeukemiaUnited States
-
Korea University Anam HospitalThe Catholic University of Korea; Keimyung University Dongsan Medical Center; Medical AI Co., LtdNot yet recruitingUrologic Cancer | Myocardial Injury After Non-cardiac Surgery | Major Adverse Cardiovascular Events (MACE)
-
Montefiore Medical CenterNot yet recruitingCesarean Scar Defect (Isthmocele)United States
-
SanofiNot yet recruiting